申请人:Ge Min
公开号:US20090253673A1
公开(公告)日:2009-10-08
Certain novel N-acylated spiropiperidine derivatives are ligands of the human ghrelin receptor(s) and, in particular, are antagonists/inverse agonists of the human ghrelin receptor. They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of the ghrelin receptor, such as obesity, diabetes, and metabolic syndrome.
某些新型N-酰化螺环哌啶衍生物是人类胃饥素受体的配体,特别是人类胃饥素受体的拮抗剂/逆向激动剂。因此,它们对于治疗、控制或预防对胃饥素受体调节敏感的疾病和疾病是有用的,如肥胖症、糖尿病和代谢综合征。